Training held on monitoring of Covid immunisation affects
Islamabad
February 9, 2021
Islamabad:The Drug Regulatory Authority of Pakistan (DRAP), in collaboration with World Health Organisation, arranged a one-day training session on monitoring of Adverse Event Following Immunisation (AEFI) of COVID-19 vaccine here on Monday.
Representatives from the Pakistan National Pharmacovigilance Centre (PNPC), DRAP, federal and provincial Expanded Programmes on Immunization, and focal persons of pharmacovigilance from the provinces attended the training.
Dr. Abdur Rashid, Director, Division of Pharmacy and Head of PNPC welcomed the participants. He briefly explained the role of DRAP in general and the Division of Pharmacy Services in particular in the process of approval of clinical trials of COVID-19 vaccines in Pakistan and subsequent monitoring of AEFIs after their registration. He also explained the role and responsibilities of each stakeholder.